AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Dashglim-M3 Tablet PR

Prescription Icon
Prescription Required

Marketer

Dashak Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Dashglim-M3 Tablet PR

GlucoDuo-MX tablets are antidiabetic medications combining two active ingredients to manage type 2 diabetes in adults. These tablets help regulate blood glucose. GlucoDuo-MX should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, risking complications like kidney disease, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, juice) are essential for prevention. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before using GlucoDuo-MX if pregnant or breastfeeding. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Dashglim-M3 Tablet PR

No text provided to rephrase.

Uses of Dashglim-M3 Tablet PR

Managing type 2 diabetes

Major Benefits of Dashglim-M3 Tablet PR:

Follow your physician's instructions or refer to the product label for dosage guidance. Consume Dashglim-M3 Tablet PR with a meal.

Common Side effects of Dashglim-M3 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Dashglim-M3 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidance. Administer Dashglim-M3 Tablet PR with meals.

How Dashglim-M3 Tablet PR works:

Dashglim-M3 PR tablets contain a dual-action formulation of glimepiride and metformin, both used in diabetes management. Glimepiride, a sulfonylurea agent, stimulates pancreatic insulin release, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Dashglim-M3 Tablet PR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dashglim-M3 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to any prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Using Dashglim-M3 Tablet PR while breastfeeding is contraindicated due to potential infant toxicity. Research indicates the medication may harm the nursing infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Dashglim-M3 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Dashglim-M3 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for those with mild to moderate hepatic dysfunction; however, its use is contraindicated in patients with severe liver disease.

What if you forget to take Dashglim-M3 Tablet PR :

Should you forget a Dashglim-M3 Tablet PR dose, take it immediately if you remember. If your next dose is imminent, however, omit the missed dose and resume your usual medication routine. Never take a double dose.

Facts to Know About Dashglim-M3 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dashglim-M3 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Dashglim-M3 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Dashglim-M3 Tablet PR and seek immediate medical attention.
Dashglim-M3 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Dashglim-M3 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Dashglim-M3 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Dashglim-M3 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Dashglim-M3 Tablet PR and alcohol is unsafe. Alcohol can worsen the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Dashglim-M3 Tablet PR
86
MRP 100
14% off